A new TB vaccine for adolescents and adults, developed by IIT and ILS Bhubaneswar, is set for commercialisation.

India is moving closer to commercialising a new tuberculosis vaccine — the HSP Subunit Vaccine in Adjuvant (DDA). Developed ...

Wealthier consumptive patients had long been directed to salubrious locations such as seaside resorts or spa towns to escape ...

In a significant breakthrough, the Institute of Life Sciences (ILS), Bhubaneswar has developed a next-generation subunit ...

The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...

Tuberculosis (TB) continues to be one of the world's leading causes of infectious disease-related illness and death. Despite ...

Pulmonary diseases pose a major health problem worldwide with millions of affected individuals and dire economic impact.

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

German researchers studying tuberculosis that spreads beyond the lungs identified unique immune patterns in patients’ blood.

IIT Bhubaneswar and ILS transferred novel TB vaccine technology to TechInvention, facilitated by NRDC, to combat tuberculosis ...

A groundbreaking study from the University of Cape Town reveals that most tuberculosis cases are asymptomatic at screening, ...

The United States endobronchial ultrasound (EBUS) biopsy market is projected to grow from USD 246.82 billion in 2024 to USD ...